Concerns Over Medicare Advantage: A Personal Experience

Tom, a retired firefighter from Texas, brushed off his stomach pain initially. He thought it was nothing serious, but after losing 30 pounds in just three weeks, his doctor recommended a CT scan. At 65, Tom had recently qualified for Medicare benefits, so he felt somewhat reassured.

Like many others, Tom switched his insurance after being approached by a broker who promised low premiums and even offered gift cards. However, it turned out that the benefits were overshadowed by a system that frequently delayed and denied compensation, which was concerning given that these plans were privately managed rather than tied directly to traditional Medicare.

About three months after the CT scan, Tom learned he had an abdominal mass. The path to getting timely treatment was filled with red tape: finding an oncologist in his network, navigating further referrals, waiting for approvals, and finally scheduling a biopsy. This long wait ultimately led to a grim diagnosis of stage 3 pancreatic cancer.

Upon hearing the news, Tom asked, “It’s okay, right?” His instinct to seek reassurance was evident, but it quickly became clear that his treatment options were dictated more by his insurance than by the medical needs dictated by his condition. This same insurance, supposedly designed to offer him an advantage, had postponed essential testing and care in his time of need.

Medicare was intended to support better healthcare for older adults, but in practice, it often shifts the financial burden away from the government and onto private companies like UnitedHealth Group, Humana, and CVS Health. While Medicare Advantage may provide decent coverage when someone is healthy, a critical illness can lead to overwhelming medical debt—an issue that plagues nearly 40% of Americans during their lifetime.

Over the last two decades, about $45 billion in taxpayer money has shown that Medicare Advantage can be riddled with issues like corruption and fraud. Still, 32.8 million elderly Americans—around 54% of those eligible—are enrolled. In 2023 alone, Medicare Advantage rejected around 3.2 million prior authorization requests completely or partially.

Many seniors struggle with the complexities of insurance while trying to battle serious illnesses like cancer. Consequently, a significant number end up paying out of pocket for medications due to delays or denials from insurers. In fact, last year, 79% of patients faced some form of coverage denial, which only adds to the burden of medical debt, impacting over 100 million Americans.

Interestingly, an appeal process is often available, and statistics suggest that over 80% of appeals were approved between 2019 and 2023. This raises questions about the validity of the initial claims and the supposed efficiency that Medicare Advantage promised.

The emotional toll of these insurance struggles can be devastating. Patients find it difficult to cope with not just the fear of their illnesses but the overwhelming anxiety and depression brought on by an insurance system that feels indifferent to their suffering.

During one of Tom’s chemotherapy sessions, he found himself physically drained, with his skin looking pale as he desperately relied on his insurance to cover the exorbitant costs. His story sheds light on a troubling reality: the so-called advantages of Medicare often fail to support older cancer patients adequately.

Experts recommend that patients consider secondary or supplementary insurance alongside traditional Medicare to avoid the pitfalls of Medicare Advantage. Unfortunately, many delay signing up for this additional coverage, often thinking they won’t need it or believing they’ll have time before deadlines arrive—typically within a few months of their 65th birthday.

Even though supplementary plans can be costly, often around $500 a month, the overall out-of-pocket expenses are often more manageable compared to the potential costs associated with Medicare Advantage. For instance, Tom quickly racked up an annual self-pay of $8,500, and after just four months of treatment, he was facing a staggering $17,000 bill for standard care.

If luck has smiled upon you and you’ve remained healthy, Medicare Advantage might appear economical. But for those who are vulnerable, especially during illness, it presents significant challenges. A bipartisan effort exists to reassess the insurance model, as concerns have emerged about the practices of Medicare Advantage companies.

During his confirmation hearing, Mehmet Oz criticized these companies for some of their restrictive practices. Proposed changes could involve eliminating out-of-pocket costs for cancer patients, limiting insurers’ ability to deny physician-initiated claims, and encouraging greater oversight.

Politics may often divide opinions, but there seems to be common ground on one critical issue: individuals like Tom, alongside millions of other Americans enrolled in Medicare Advantage, deserve more comprehensive and fair healthcare solutions.

Dr. Pramod Pinnamaneni and Dr. Nitya Thummalachetty of the NAU Project—a startup aimed at helping everyday Americans navigate the complexities of the healthcare system—emphasize this urgent need for change.